Table 1 Reported use of intraprostatic focal radiotherapy boost, by category
Category | Routinely use focal boost (95% CI) | p value |
|---|---|---|
Degree of GU-subspecialization | ||
Generalist (n = 68) | 31% (21%, 43%) | 0.0001 |
Partly subspecialized (n = 119) | 40% (32%, 49%) | 0.002 |
Completely subspecialized (n = 70) | 61% (50%, 73%) | Reference |
Country’s income* | ||
Low- to middle-income (n = 79) | 35% (25%, 47%) | 0.08 |
High-income (n = 164) | 45% (37%, 53%) | Reference |
Declined to state (n = 15) | 67% (40%, 87%) | 0.05 |
Practice setting | ||
Academic medical center (n = 133) | 48% (40%, 56%) | Reference |
Non-academic hospital (n = 21) | 38% (19%, 62%) | 0.19 |
Academic-affiliated community hospital (n = 38) | 37% (21%, 53%) | 0.10 |
Non-academic community hospital (n = 20) | 40% (20%, 60%) | 0.24 |
Independent/private practice (n = 44) | 36% (23%, 50%) | 0.08 |
# of PCa cases treated per month | ||
1–4 cases (n = 85) | 34% (25%, 45%) | Reference |
5–10 cases (n = 97) | 41% (32%, 52%) | 0.16 |
> 10 cases (n = 73) | 55% (44%, 66%) | 0.004 |